In this Issue:
Sofosbuvir-containing retreatment regimens achieve SVR
Role of NTCP in bile acid handling and HBV pathobiology
Distinct blood gene signatures characterise HBV clinical phases
Sofosbuvir/ledipasvir effective, safe, in HCV G1 cirrhosis
HBV reactivation during biologic therapy
Effective antivirals normalise NK cell phenotype and function
HBcAg-specific CD8+ T cells after HBsAg clearance
Drug-drug interactions for the 3D regimen of OBV, PTV/r, and DSV
Understanding how CMV may modulate hepatic immunity
Distinguishing HBV-associated acute on chronic liver failure
Please login below to download this issue (PDF)